Regular Article
Evidence for Normal Aging of the Septo-Hippocampal Cholinergic System in apoE (−/−) Mice but Impaired Clearance of Axonal Degeneration Products Following Injury

https://doi.org/10.1006/exnr.1998.6818Get rights and content

Abstract

The association of the ϵ4 allele of apoE with increased risk for Alzheimer's disease (AD) and with poor clinical outcome after certain acute brain injuries has sparked interest in the neurobiology of apoE. ApoE (−/−) mice provide a tool to investigate the role of apoE in the nervous systemin vivo.Since integrity of the basal forebrain cholinergic system is severely compromised in AD, with severity of dysfunction correlating with apoE4 gene dosage, the present study tested the hypothesis that apoE is required to maintain the normal integrity of basal forebrain cholinergic neurons (BFCNs). Histological and biochemical analyses of the septo-hippocampal cholinergic system were performed in apoE (−/−) mice during aging and following injury. Using unbiased quantitative methods, there was little or no evidence for defects in the septo-hippocampal cholinergic system, as assessed by p75NTR-immunoreactive neuron number and size in the medial septum, cholinergic fiber density in the hippocampus, and choline acetyltransferase activity in the hippocampus, cortex, and striatum in aged apoE (−/−) mice (up to 24 months of age) as compared to age-matched wild-type mice of the same strain. In addition, cholinergic neuronal survival and size following fimbria–fornix transection in apoE (−/−) mice did not differ from controls. However, following entorhinal cortex lesion, there was persistence of degeneration products in the deafferented hippocampus in apoE (−/−) mice. These data suggest that although apoE is not required for the maintenance of BFCNsin vivo,it may play a role in the clearance of cholesterol-laden neurodegeneration products following brain injury.

References (75)

  • F. Hefti et al.

    Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septohippocampal lesions

    Brain Res.

    (1984)
  • F. Hefti et al.

    Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain

    Neurosci. Lett.

    (1986)
  • D.M. Holtzman et al.

    NOS induction by NGF in basal forebrain cholinergic neurons: evidence for regulation of brain NOS by a neurotrophin

    Neurobiol. Disease

    (1994)
  • A.R. Koudinov et al.

    Biochemical characterization of Alzheimer's soluble beta protein in human cerebrospinal fluid—association with high density lipoprotein

    Biochem. Biophys. Res. Commun.

    (1996)
  • E. Masliah et al.

    Neurodegeneration in the central nervous system of apoE-deficient mice

    Exp. Neurol.

    (1995)
  • D. Matthews et al.

    An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and timecourse of degeneration

    Brain Res.

    (1976)
  • M. Nakai et al.

    Expression of apolipoprotein E mRNA in rat microglia

    Neurosci. Lett.

    (1996)
  • Y. Namba et al.

    Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease

    Brain Res.

    (1991)
  • R.E. Pitas et al.

    Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

    Biochim. Biophys. Acta

    (1987)
  • R.E. Pitas et al.

    Lipoproteins and their receptors in the central nervous system

    J. Biol. Chem.

    (1987)
  • A.S. Plump et al.

    Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

    Cell

    (1992)
  • J. Poirier et al.

    Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

    Mol. Brain Res.

    (1991)
  • H. Soininen et al.

    A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ϵ4 allele

    Neurosci. Lett.

    (1995)
  • D.J. Stone et al.

    Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro

    Exp. Neurol.

    (1997)
  • M.H. Tuszynski et al.

    Basal forebrain cell loss following fimbria/fornix transection

    Brain Res.

    (1990)
  • G. Weskamp et al.

    Evidence that biological activity of NGF is mediated through a novel subclass of high-affinity receptors

    Neuron

    (1991)
  • M.J. West

    New stereological methods for counting neurons

    Neurobiol. Aging

    (1993)
  • T. Wisniewski et al.

    Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid

    Neurosci. Lett.

    (1992)
  • L. Xin et al.

    A deficiency of axonal regeneration in C57Bl/6J mice

    Brain Res.

    (1990)
  • K.R. Bales et al.

    Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

    Nature Gen.

    (1997)
  • J.K. Boyles et al.

    Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

    J. Clin. Invest.

    (1985)
  • B. Cavalieri

    Geometria Degli Indivisibili

    (1966)
  • E.H. Corder et al.

    Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

    Science

    (1993)
  • J.T. Coyle et al.

    Alzheimer's disease: a disorder of cortical cholinergic innervation

    Science

    (1983)
  • N.A. Elshourbagy et al.

    Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

    Proc. Natl. Acad. Sci. USA

    (1985)
  • A.M. Fagan et al.

    A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo

    J. Neurosci.

    (1997)
  • A.M. Fagan et al.

    Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus

    J. Neurosci.

    (1997)
  • Cited by (107)

    • Animal Models of Alzheimer's Disease

      2017, Neuroprotection in Alzheimer's Disease
    • Alzheimer's Disease Therapeutics Targeting Apolipoprotein E

      2016, Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
    View all citing articles on Scopus

    R. TerryR. KatzmanK. Bick

    1

    To whom correspondence and reprint requests should be addressed. Fax: (314) 362-9462. E-mail: [email protected]

    2

    Present address: Department of Neurology, Room H3160, Stanford University Medical Center, Stanford, CA 94305.

    View full text